Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique

Clinical and Experimental Immunology

Volumn 144, Issue 1, 2006, Pages 53-58

  Monstad, S E ^a   Storstein, A ^a   Dorum A ^c   Knudsen, A ^a   Lonning P E ^a   Salvesen, H B ^a,b   Aarseth, J H ^a   Vedeler, C A ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast cancer; cdr2; Immunoprecipitation; ovarian cancer; Paraneoplastic syndrome; Yo antibody

Indexed keywords

ANTIBODY; EDETIC ACID; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; YO ANTIBODY;

ADULT; ADVANCED CANCER; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HISTOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; IN VITRO STUDY; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NONHUMAN; OVARY CANCER; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TRANSCRIPTION INITIATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOPRECIPITATION; MIDDLE AGED; NEOPLASM STAGING; NERVE TISSUE PROTEINS; OVARIAN NEOPLASMS; PARANEOPLASTIC CEREBELLAR DEGENERATION;

EID: 33645101565     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03031.x     Document Type: Article

References (24)

1. Roberts WK Darnell RB. Neuroimmunology of the paraneoplastic neurological degenerations Curr Opin Immunol 2004 16 616 22
2. Peterson K Rosenblum MK Kotanides H Posner JB. Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti-Yo antibody positive patients Neurology 1992 42 1931 7
3. Shams'ili S Grefkens J de Leeuw B et al Paraneoplastic cerebellar degeneration associated with antineuronal antibodies. analysis of 50 patients Brain 2003 126 1409 18
4. Albert ML Darnell JC Bender A et al Tumor-specific killer cells in paraneoplastic cerebellar degeneration Nat Med 1998 4 1321 4
5. Albert ML Austin LM Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration Ann Neurol 2000 47 9 17
6. Darnell JC Albert ML Darnell RB. Cdr2, a target antigen of naturally occurring human tumor immunity, is widely expressed in gynecological tumours Cancer Res 2000 60 2136 9
7. Graus F Dalmau J Rene R et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival J Clin Oncol 1997 15 2866 72
8. Monstad SE Drivsholm L Storstein A et al Hu and Voltage-Gated Calcium Channel (VGCC) antibodies related to the prognosis of small-cell lung cancer J Clin Oncol 2004 22 795 800
9. Pittock SJ Kryzer TJ Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome Ann Neurol 2004 56 715 9
10. Moll JW Antoine JC Brashear HR et al. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, The Netherlands Neurology 1995 45 1937 41
11. Storstein A Monstad SE Nakkestad HL et al Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay J Neurol 2004 251 197 203
12. Fathallah-Shaykh H Wolf S Wong E et al Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration Proc Natl Acad Sci 1991 88 3451 4
13. 3H recombinant human ligands J Immunol Meth 1995 186 89 99
14. Falorni A Nikoshkov A Laureti S et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydoxylase J Clin Endocrinol Metab 1995 80 2752 5
15. Sakai K Ogasawara T Hirose G et al Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins Ann Neurol 1993 33 373 80
16. Greenbaum CJ Palmer JP Kuglin B Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay. results of the Fourth International Workshop on the standardization of Insulin Autoantibodies Measurements J Clin Endocrinol Metab 1992 74 1040 4
17. Schmidli RS Colman PG Bonifacio E et al High level of concordance between assays for glutamic acid decarboxylase antibodies The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 1994 43 1005 9
18. Drlicek M Bianchi G Bogliun G et al. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients J Neurol 1997 244 85 9
19. Graus F Delattre JY Antoine JC et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes J Neurol Neurosurg Psychiatry 2004 75 1135 40
20. Dalmau J Furneaux HM Cordon-Cardo C Posner JB. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronpathy) antigen in human normal and tumor tissues Am J Pathol 1992 141 881 6
21. Dalmau J Graus F Cheung NK et al. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer Cancer 1995 75 99 109
22. Greenlee JE Dalmau J Lyons T et al Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder. Detection of Yo antigen in tumor tissue and fall in antibody titres following tumour removal Ann Neurol 1999 45 805 9
23. Rojas I Graus F Keime-Guibert F et al Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies Neurology 2000 55 713 5
24. Brashear HR Greenlee JE Jaeckle KA Rose JW. Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms Neurology 1989 39 1605 9